AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) Director Ecor1 Capital, Llc acquired 84,120 shares of the company's stock in a transaction that occurred on Monday, November 16th. The stock was bought at an average price of $45.66 per share, with a total value of $3,840,919.20. Following the...